Abstract
Complement deficient patients are susceptible to rare meningococcal serogroups. A 6-year-old girl presented with serogroup Z meningitis. This led to identification of a C8 deficiency. The MenB-4C vaccine induced cross-reactive antibodies to serogroup Z and increased in vitro opsonophagocytic killing and may thus protect complement deficient patients.
Original language | English |
---|---|
Pages (from-to) | 1019-1022 |
Number of pages | 4 |
Journal | Pediatric Infectious Disease Journal |
Volume | 40 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2021 |
Keywords
- complement deficiency
- immune compromised
- MenB-4C
- Neisseria meningitidis
- vaccine